Picture of BICO AB logo

BICO BICO AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m+12.9%
3m-8.66%
6m+44.4%
1yr-20.31%
Volume Change (%)
10d/3m-45.13%
Price vs... (%)
52w High-38.81%
50d MA-1.68%
200d MA-0.47%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-20.56%
Return on Equity-28.79%
Operating Margin-64.44%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueSEKm105.46416.011,257.32,120.82,249.92,4622,847118.34%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-54.71n/an/an/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of BICO AB EPS forecast chart

Profile Summary

BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
February 9th, 2016
Public Since
November 3rd, 2016
No. of Shareholders
22,600
No. of Employees
884
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
70,574,895

BICO Share Price Performance

Upcoming Events for BICO

Q1 2024 BICO Group AB Earnings Release

BICO Group AB Annual Shareholders Meeting

Q2 2024 BICO Group AB Earnings Release

Similar to BICO

Picture of Acarix AB logo

Acarix AB

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of Aegirbio AB logo

Aegirbio AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Arcoma AB logo

Arcoma AB

se flag iconOMX Nordic Exchange Stockholm

FAQ